Thank you.
I now want to ask a question of you, Dr. Weaver. I appreciate what you had to say about your definition of innovation. Our government, the federal government, is cutting red tape and streamlining the regulatory process in terms of approving new drugs. Are there any areas where we can further support innovation, as you would describe it, by cutting red tape without compromising the safety of new drugs or medical devices?